e-learning
resources
ERJ
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study
Ellis Huw C., Cowman Steven, Fernandes Michele, Wilson Robert, Loebinger Michael R.
Source:
Eur Respir J 2016; 47: 482-489
Journal Issue:
February
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ellis Huw C., Cowman Steven, Fernandes Michele, Wilson Robert, Loebinger Michael R.. Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study. Eur Respir J 2016; 47: 482-489
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
ERS clinical practice guidelines on bronchiectasis in children
Related content which might interest you:
The bronchiectasis severity index (BSI) and FACED score for assessment the severity of bronchiectasis
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
The bronchiectasis severity index and FACED score for bronchiectasis
Source: Eur Respir J 2016; 47: 382-384
Year: 2016
Evaluation of DECAF, CURB-65 and BAP-65 scales as predictor of mortality risk in acute exacerbation of COPD in a retrospective cohort
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017
Contribution of BSI and FACED scores in prediction of bronchiectasis mortality
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
Impact of chronic obstructive pulmonary disease on specific-cause of mortality: a national cohort study
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019
Relation between quality of life and morbidity and mortality in COPD patients: 7-year follow-up study
Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care
Year: 2011
Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis.
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020
The annual prognostic ability of FACED and E-FACED scores to predict mortality in patients with bronchiectasis
Source: ERJ Open Res, 4 (1) 00139-2017; 10.1183/23120541.00139-2017
Year: 2018
Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
Predictors of exacerbations in hospitalised patients with bronchiectasis: A retrospective study in an Asian population
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study
Source: Eur Respir J, 56 (3) 2002113; 10.1183/13993003.02113-2020
Year: 2020
Predicting 12-month mortality in a Scottish COPD cohort
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Rheumatoid arthritis and bronchiectasis: A multicentre study assessing pulmonary disease severity using the bronchiectasis severity index (BSI)
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Excess economic burden of comorbidities in COPD: a 15-year population-based study
Source: Eur Respir J, 50 (1) 1700393; 10.1183/13993003.00393-2017
Year: 2017
Clinical examination and all-cause mortality in non-mild COPD population – prospective study
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
Source: Eur Respir J, 57 (3) 2001339; 10.1183/13993003.01339-2020
Year: 2021
A prospective study of the relationship of severity assessed by modified CURB-65 score and mortality in patients with commmunity acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 374s
Year: 2006
Body mass index at school age and hospital admissions for asthma and chronic obstructive pulmonary disease in middle-age and elderly adults: A prospective study of 240,293 children
Source: International Congress 2019 – Asthma epidemiology in the 21st century
Year: 2019
Prognosis of COPD according to exacerbation history: a population-based cohort study
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019
Bronchiectasis exacerbations risk prediction using severity scales BSI and FACED
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept